$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

형질전환 식물세포배양을 이용한 바이오의약품 생산
Production of biopharmaceuticals in transgenic plant cell suspension cultures 원문보기

Journal of plant biotechnology = 식물생명공학회지, v.36 no.4, 2009년, pp.309 - 319  

권준영 (인하대학교 생물공학과) ,  전수환 (인하대학교 생물공학과) ,  이혜란 (인하대학교 생물공학과) ,  한지연 (인하대학교 생물공학과) ,  김동일 (인하대학교 생물공학과)

Abstract AI-Helper 아이콘AI-Helper

Transgenic plant cell cultures for the production of biopharmaceuticals including monoclonal antibodies, recombinant proteins have been regarded as an alternative platform in addition to traditional microbial fermentation and mammalian cell cultures. Plant-made pharmaceuticals (PMPs) have several ad...

AI 본문요약
AI-Helper 아이콘 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

문제 정의

  • 바이오의약 단백질의 상업화를 위해서는 bioreactor에서의 대량배양이 필수적이므로, 형질전환 식물세포에 적합한 bioreactor 배양공정이 확립되어야 한다. 따라서 성공적인 식물세포 bioreactor 배양을 위한 고려사항, 식물세포용 bioreactor의 종류, 바이오의약 단백 질의허가와 생산성 증대를 위한 bioreactor 배양공정 최적화 전략에 대해서도 최근의 동향을 알아보고자 하였다.
  • 본 총설에서는 먼저 형질전환 식물세포배양을 이용한바 이오의 약 단백질의 상업화를 위해 필요한 식물 유래 당쇄화의 최근 연구방향과, 생산성 증대를 위해 세포주 수준에서 고려할 측면에 대해서 정리하였다. 고생산 세포주가 선별된 후의 단백질 생산성은 bioreactor 공정상에서 좌우된다.
  • 고생산 세포주의 선별과정 이후에는, 세포에 적합한 bioreactor 를 선정하고, 생산 공정의 개발 및 최적화에 의해서 생산성 증대가 가능하다. 이 장에서는 bioreactor 공정 측면에서 bioreactor 종류와 식물세포배양 시 주로 고려해야 하는 사항에 대해 언급하고자 한다.
본문요약 정보가 도움이 되었나요?

참고문헌 (46)

  1. Abdullah MA, Ariff AB, Marziah M, Ali AM, Lajis NH (2000) Strategies to overcome foaming and wall-growth during the cultivation of Morinda elliptica cell suspension culture in a stirred-tank bioreactor. Plant Cell Tiss Org Cult 60:205-212 

  2. Aviezer D, Brill-Almon E, Shaaltiel Y, Hashmueli S, Bartfeld D, Mizrachi S, Liberman Y, Freeman A, Zimran A, Galun E (2009) A plant-derived recombinant human glucocerebrosidase enzyme: A preclinical and phase I investigation. Plos Med 4: 1-5 

  3. Bakker H, Bardor M, Molthoff JW, Gomord V, Elvers I, Stevens LH, Jordi W, Lommen A, Faye L, Lerouge P, Bosch D (2001) Galactose-extended glycans of antibodies produced by transgenic plants. Proc Natl Acad Sci USA 98:2899-2904 

  4. Barnes LM, Dickson AJ (2006) Mammalian cell factories for efficient and stable protein expression. Curr Opinion Biotechnol 17:381-386 

  5. Betts JI, Baganz F (2006) Miniature bioreactors: current practices and future opportunities. Microb Cell Fact 5:21-34 

  6. Bohme C, Schroder MB, JungHeiliger H, Lehmann J (1997) Plant cell suspension culture in a bench-scale fermenter with a newly designed membrane stirrer for bubble-free aeration. Appl Microbiol Biotechnol 48:149-154 

  7. Castilho A, Pabst M, Leonard R, Veit C, Altmann F, Mach L, Glossl J, Strasser R, Steinkellner H (2008) Construction of a functional CMP-sialic acid (CMP-Neu5Ac) biosynthesis pathway in Arabidopsis thaliana. Plant Physiol 147:331-339 

  8. Doran PM (1999) Design of mixing systems for plant cell suspensions in stirred reactors. Biotechnol Prog 15:319-335 

  9. Doran PM (2006) Foreign protein degradation and instability in plants and plant tissue cultures. Trends Biotechnol 24: 426-432 

  10. Eibl R, Eibl D (2008) Design of bioreactors suitable for plant cell and tissue cultures. Phytochem Rev 7:593-598 

  11. Fox JL (2006) Turning plants into protein factories. Nat Biotechnol 24:1191-1193 

  12. Gill NK, Appleton M, Baganz F, Lye GJ (2008) Quantification of power consumption and oxygen transfer characteristics of a stirred miniature bioreactor for predictive fermentation scaleup. Biotechnol Bioeng 100:1144-1155 

  13. Girard LS, Fabis MJ, Bastin M, Courtois D, Petiard V, Koprowski H (2006) Expression of a human anti-virus monoclonal antibody in tobacco cell culture. Biochem Biophys Res Comm 345:602-607 

  14. Gomord V, Faye L (2004) Posttranslational modification of therapeutic proteins in plants. Curr Opin Plant Biol 7:171-181 

  15. Gotoh T, Miyazaki Y, Sato W, Kikuchi K, Bentley WE (2001) Proteolytic activity and recombinant protein production in virus-infected Sf-9 insect cell cultures supplemented with carboxyl and cysteine protease inhibitors. J Biosci Bioeng 92: 248-255 

  16. Huang TK, McDonald KA (2009) Bioreactor engineering for recombinant protein production in plant cell suspension cultures. Biochem Eng J 45:168-184 

  17. Huang TK, Plesha MA, Falk BW, Dandekar AM, Mcdonald KA (2009) Bioreactor strategies for improving production yield and functionality of a recombinant human protein in transgenic tobacco cell cultures. Biotechnol Bioeng 102:508-520 

  18. Jefferis R (2009) Glycosylation as a strategy to improve antibody-based therapeutics. Nat Drug Discov 8:226-234 

  19. Kwon TH, Kin YS, Lee JH, Yang MS (2003) Production and secretion of biologically active human granulocyte-macrophage colony stimulating factor in transgenic tomato suspension cultures. Biotechnol Lett 25:1571-1574 

  20. Lee SJ, Park CI, Park MY, Jung HS, Ryu WS, Lim SM, Tan HK, Kwon TH, Yang MS, Kim DI (2007) Production and characterization of human CTLA4Ig expressed in transgenic rice cell suspension cultures. Protein Expr Purif 51:293-302 

  21. Lerouge P, Bardor M, Pagny S, Gomord V, Faye L (2000) N-glycosylation of recombinant pharmaceutical glycoproteins produced in transgenic plants: towards an humanisation of plant N-glycans. Curr Pharm Biotechnol 1:347-354 

  22. Mandenius CF, Brundin A (2008) Bioprocess optimization using design-of-experiments methodology. Biotechnol Prog 24: 1191-1203 

  23. Miele L (1997) Plants as bioreactors for biopharmaceutical: regulatory considerations. Trends Biotechnol 15:45-50 

  24. Misaki R, Kimura Y, Palacpac NQ, Yoshida S, Fujiyama K, Seki T (2003) Plant cultured cells expressing human b1,4-galactosyltransferase secrete glycoproteins with galactoseextended N-linked glycans. Glycobiology 13:199-205 

  25. Pervin B, Emilio RC (2008) Plant molecular farming: Opportunities and challenges. Crit Rev Biotechnol 28:153-172 

  26. Raposo S, Lima-Costa ME (2006) Rheology and shear stress of Centaurea calcitrapa cell suspension cultures grown in bioreactor. Biotechnol Lett 28:431-438 

  27. Ritala A, Wahlstro EH, Holkeri MH, Hafren A, Makelainen K, Baez J, Makinen K, Nuutila AM (2008) Production of a recombinant industrial protein using barley cell cultures. Protein Expr Purif 59:274-281 

  28. Roberts SG, Shuler ML (1997) Large-scale plant cell culture. Curr Opinion Biotechnol 8:154-159 

  29. Shinmyo A, Shoji T, Bando E, Nagaya S, Nakai Y, Kato K, Sekine M, Yoshida K (1998) Metabolic engineering of cultured tobacco cells. Biotechnol Bioeng 58:329-332 

  30. Sowana DD, Williams DRG, Dunlop EH, Dally BB, O'Neill BK, Fletcher DF (2001) Turbulent shear stress effects on plant cell suspension cultures. Trans I Chem E 79:867-875 

  31. Strasser R, Altmann F, Mach L, Glossl J, Steinkellner H (2004) Generation of Arabidopsis thaliana plants with complex N-glycans lacking b1,2-linked xylose and core a1,3-linked fucose. FEBS Letters. 561:132-136 

  32. Taticek RA, Legge RL (1991) The scale-up of plant cell culture: engineering considerations. Plant Cell Tiss Organ Cult 24: 139-159 

  33. Terashima M, Murai Y, Kawamura M, Nakanishi S, Stoltz T, Chen L, Drohan W, Rodriguez RL, Kotoh S (1999) Production of functional human a1-antitrypsin by plant cell culture. Appl Microbiol Biotechnol 52:516-523 

  34. Terashima M, Ejiri Y, Hashikawa N, Yoshida H (2000) Effect of sugar concentration of recombinant human a1-antitrypsin production by genetically engineered rice cell. Biochem Eng J 6:201-205 

  35. Terashima M, Ejiri Y, Hashikawa N, Yoshida H (2001) Utilization of an alternative carbon source for efficient production of human a1-antitrypsin by genetically engineered rice cell culture. Biotechnol Prog 17:403-406 

  36. Terashima M, Hashikawa N, Hattori M, Yoshida H (2002) Growth charateristic of rice cell genentically modified for recombinant human a1-antitrypsin production. Biochem Eng J 12: 155-160 

  37. Trexler MM, Mcdonald KA, Jackman AP (2005) A cyclical semicontinuous process for production of human a1-antitrypsin using metabolically induced plant cell suspension cultures. Biotechnol Prog 21:321-328 

  38. Tsoi, BM, Doran PM (2002) Effect of medium properties and additives on antibody stability and accumulation in suspended plant cell cultures. Biotechnol Appl Biochem 35: 171-180 

  39. Twyman RM, Stoger E, Schillberg S, Christou P, Fischer R (2003) Molecular farming in plants: Host systems and expression technology. Trends Biotechnol 21:570-578 

  40. Wang PM, Huang TK, Cheng HP, Chien YH, Wu WT (2002) A modified airlift reactor with high capabilities of liquid mixing and mass transfer. J Chem Eng Jpn 35:354-359 

  41. Warzecha H (2008) Biopharmaceuticals from plants: a multitude of options for posttranslational modifications. Biotechnol Genetic Eng Rev 25:315-330 

  42. Williams GRC, Doran PM (2000) Hairy root culture in a liquiddispersed bioreactor: Characterization of spatial heterogeneity. Biotechnol Prog 16:391-401 

  43. Yin JC, Li GX, Ren XF, Herrler G (2007) Select what you need: a comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes. J Biotechnol 127:335-347 

  44. Zhang S, Handa-Corrigan A, Spier RE (1992) Foaming and media surfactant effects on the cultivation of animal cells in stirred and sparged bioreactors. J Biotechnol 25:289-306 

  45. Zhong JJ, Yu JT, Yoshida T (1995) Recent advance in plant cell cultures in bioreactors. World J Microbiol Biotechnol 11: 461-467 

  46. Zhong JJ, Chen F, Hu WW (1999) High density cultivation of Panax notoginseng cells in stirred bioreactor for the production of ginseng biomass and ginseng saponin. Process Biochem 35:491-496 

저자의 다른 논문 :

LOADING...

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로